Mainstream

Omeros signals debt reduction of over $100M and prioritizes narsoplimab launch following FDA BLA acceptance

Omeros signals debt reduction of over $100M and prioritizes narsoplimab launch following FDA BLA acceptance

Post ContentomerRead More

You might also be interested in reading Why Is Derivatives Giant CME Partnering With Sports Bettors? Prediction Markets Boom Holds the Answer.

May 16, 2025
In Mainstream